Skip to main content
Fig. 3 | BMC Genomics

Fig. 3

From: Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients

Fig. 3

Identification of two DGs clusters and differences in prognosis, TME, and clinicopathological features. A-C All ccRCC patients from the TCGA cohort were divided into two DGs clusters by unsupervised consensus clustering analysis (k = 2). The Cumulative Distribution Function (CDF) curve for k = 2–9. Area under the CDF curve for k = 2–9. D The principal component analysis displays significant differences of two DGs clusters. E Kaplan–Meier survival curve of two DGs clusters. F The heatmap includes clinicopathological features and expression profiles of 13 DGs in the TCGA cohort. G The infiltration levels of 28 human immune cell subtypes between two DGs clusters. H The Immune, Stromal, and ESTIMATE scores of two DGs clusters. I KEGG analysis of DEGs in two DGs clusters. *P < 0.05, **P < 0.01, ***P < 0.001, ns: no significance

Back to article page

BMC Genomics

ISSN: 1471-2164

Contact us